1 Lu, H., Stratton, C. & Tang, Y.-W. Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle. Journal of Medical Virology 92, doi:10.1002/jmv.25678 (2020).
2 Hui, D. S. et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 91, 264-266, doi:10.1016/j.ijid.2020.01.009 (2020).
3 Paules, C. I., Marston, H. D. & Fauci, A. S. Coronavirus Infections-More Than Just the Common Cold. JAMA, doi:10.1001/jama.2020.0757 (2020).
4 Wuhan Municipal Health Commission.Report of clustering pneumonia of unknown etiology in Wuhan City. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989 (Accessed 31 January 2020).
5 Wuhan Municipal Health Commission.Report of novel coronavirus-infected pneumonia in China. http://wjw.wuhan.gov.cn/front/web/ShowDetail/2020012009077 (Accessed 31 January 2020).
6 Drosten, C. et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348, 1967-1976 (2003).
7 THE CENTRAL PEOPLE’S GOVERNMENT OF THE PEOPLE’S REPUBLIC OF CHINA.National Health Commission's briefing on the pneumonia epidemic situation. http://www.nhc.gov.cn/yjb/s7860/202001/9614b05a8cac4ffabac10c4502fe517c.shtml (Accessed 23 Feb 2020).
8 Zhu, N. et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 382, 727-733, doi:10.1056/NEJMoa2001017 (2020).
9 Li, Q. et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med 382, 1199-1207, doi:10.1056/NEJMoa2001316 (2020).
10 Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497-506, doi:10.1016/S0140-6736(20)30183-5 (2020).
11 Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507-513, doi:10.1016/S0140-6736(20)30211-7 (2020).
12 Wang, D. et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, doi:10.1001/jama.2020.1585 (2020).
13 World Health Organization.Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV)infection is suspected: interim guidance https://www.who.int/internalpublications-detail/clinical-management-of-severe-acute-respiratoryinfection (Accessed 20 Jan 2020).
14 Thygesen, K. et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation 138, e618-e651, doi:10.1161/CIR.0000000000000617 (2018).
15 Tavazzi, G. et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail, doi:10.1002/ejhf.1828 (2020).
16 Smeeth, L. et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351, 2611-2618 (2004).
17 Davidson, J. A. & Warren-Gash, C. Cardiovascular complications of acute respiratory infections: current research and future directions. Expert Rev Anti Infect Ther 17, 939-942, doi:10.1080/14787210.2019.1689817 (2019).
18 Knaus, W. A., Draper, E. A., Wagner, D. P. & Zimmerman, J. E. APACHE II: a severity of disease classification system. Critical care medicine 13, 818-829 (1985).
19 Xu, Z. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8, 420-422, doi:10.1016/S2213-2600(20)30076-X (2020).
20 Shi, S. et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol, doi:10.1001/jamacardio.2020.0950 (2020).
21 Guo, T. et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol, doi:10.1001/jamacardio.2020.1017 (2020).